Hypoxia-Ischemia, Brain Clinical Trial
Official title:
Development of a High-speed Multimodal Photoacoustic/Ultrasound System for Functional Imaging of the Neonatal Brain
In today's medical field, there is a growing emphasis on the development of functional and molecular imaging. Therefore, it has significant technical limitations. To address this issue, this project aims to develop a high-speed multimodal photoacoustic/ultrasound functional imaging system that provides both structural and functional information of tissue and organs, thus enhancing the accuracy of early screening and diagnosis of neonatal cranial lesions. This imaging technology is entirely non-invasive and does not involve ionizing radiation or contrast agents. Products using the same technology have already received FDA approval and entered clinical use in the United States. We develop a new generation of multimodal photoacoustic/ultrasound functional imaging equipment to reveal the physiological characteristics and structural details of neonatal cranial lesions, offering advantages and complementary information compared to traditional medical imaging methods.
Medical imaging plays a huge role in clinical diagnosis. At present, the commonly used imaging methods for neonatal brain imaging include ultrasound imaging, magnetic resonance imaging, and CT. Due to the imaging scale, speed, and radiation limitation, large imaging devices such as CT and magnetic resonance imaging usually have limitations in the early screening and diagnosis of neonatal brain lesions. With the advantages of flexibility and convenience, ultrasound has become a common imaging method for neonatal brain organs. However, conventional ultrasound imaging usually only provides structure-related information, and it is difficult to reveal the physiological characteristics of the lesions. Therefore, this project aims to develop a high-speed multi-modal photoacoustic/ultrasound functional imaging system to provide structural and functional information of tissues and organs, thereby improving the accuracy of early screening and diagnosis of neonatal brain lesions. The imaging technique is completely noninvasive and does not use any ionizing radiation or contrast media. A product that uses the same technology as this imaging device has been approved by the FDA and entered the clinic in the United States. The imaging device consists of two imaging modalities, photoacoustic imaging and ultrasound imaging. Photoacoustic imaging (PAI) can be used to image the optical absorption characteristics of human tissues by safely irradiating the human body with near-infrared light (complying with international safety standards) to produce a short time temperature rise (less than 0.1 degrees Celsius), resulting in a weak ultrasound signal. The ultrasonic imaging principle of the device is the same as that of clinical B-ultrasound, which uses ultrasound to safely irradiate the body (obeying international safety standards) and obtain reflected signals. This project is supported by the Young Scientist Project of Diagnosis and Treatment Equipment of the Key Research and Development Program of the Ministry of Science and Technology, jointly applied by the research group of Teacher Lin Li from Zhejiang University and the research group of Huang Pin from the Second Affiliated Hospital of Zhejiang University School of Medicine. This project aims to develop a new generation of multimodal photoacoustic/ultrasound functional imaging equipment to reveal the physiological characteristics and structural details of neonatal brain lesions. And traditional medical imaging methods form advantages and information complementary. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01192776 -
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
|
N/A | |
Completed |
NCT01092637 -
The TOBY Children Study
|
N/A | |
Completed |
NCT00006516 -
Home Stimulation for Brain-Asphyxiated Infants
|
Phase 2 | |
Recruiting |
NCT05390060 -
Delineating Between Pathophysiologic Phenotypes of Hypoxic Ischemic Brain Injury After Cardiac Arrest
|
N/A | |
Completed |
NCT02605733 -
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
|
||
Completed |
NCT00375908 -
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury
|
N/A | |
Completed |
NCT00005772 -
Whole-Body Cooling for Birth Asphyxia in Term Infants
|
Phase 3 | |
Completed |
NCT02991976 -
Oxygen Concentration and Recovery After Carotid Endarterectomy
|
N/A | |
Recruiting |
NCT06081283 -
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
|
Phase 4 | |
Enrolling by invitation |
NCT06168071 -
Transauricular Vagus Nerve Stimulation in Children
|
N/A | |
Completed |
NCT03112486 -
Out-of-hospital Cardiac Arrest (OHCA) Biomarkers
|
||
Completed |
NCT01793129 -
Preemie Hypothermia for Neonatal Encephalopathy
|
N/A | |
Recruiting |
NCT04217551 -
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
|
N/A | |
Completed |
NCT04261335 -
The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy
|
Phase 1 | |
Not yet recruiting |
NCT05514665 -
Functional Imaging of Baby Brains
|
||
Recruiting |
NCT06048796 -
Early Cessation of Sedation and TTM in Patients With a Favourable EEG After Cardiac Arrest
|
N/A | |
Completed |
NCT03543371 -
Neuropsychological Outcome After Cardiac Arrest
|
||
Recruiting |
NCT04198792 -
Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients
|
||
Completed |
NCT01483495 -
Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study
|
||
Completed |
NCT03941015 -
Tissue Oxygenation During Treatment of Infant Congenital Heart Defects
|